Warfarin sodium cas 129-06-6

Min.Order / FOB Price:Get Latest Price

1 Kilogram	FOB Price:USD 80.0000 -100.0000

1 Kilogram

FOB Price:USD 80.0000 -100.0000

Min.Order :1 Kilogram
Purity: 99%
Payment Terms : T/T

Keywords

Warfarin sodium cas 129-06-6 Warfarin sodium cas 129-06-6

Quick Details

Appearance:white powder
Application:CHEMICAL
PackAge:carton boc
ProductionCapacity:1000000|Metric Ton|Day
Storage:cool and dry
Transportation:COOL AND DRY

Superiority:

Chemical Name:Warfarin sodium

CAS No.129-06-6
Molecular Formula:C19H16NaO4
Formula Weight:332.331

Synonyms:3-(a-Acetonylbenzyl)-4-hydroxycoumarinsodium;Aldocumar;Athrombin;Coumadin;Coumadine;Dimantil;Marevam;Orfarin;Panwarfin;Prothromadin;Simarc 2;Sodiumwarfarin;Sofarin;Tintorane;Varfine;Waran;Warfarina;Warfil 5;Zoocoumarin sodium salt;2H-1-Benzopyran-2-one,4-hydroxy-3-(3-oxo-1-phenylbutyl)-, sodium salt (9CI);Coumarin, 3-(a-acetonylbenzyl)-4-hydroxy-, sodium salt (8CI);

Details:

Product Name: Warfarin Sodium clathrate
Other name: 3-(A-acetonylbenzyl)-4-Hydroxycoumarin
Molecular formula: C19H15NaO4
CAS No.: 129-06-6
solubility :Very soluble in water, freely soluble in ethanol (96 per cent), soluble in acetone, very slightly soluble in methylene chloride.
Molecular weight: 330.31
Chemical Properties: White or almost white, crystalline powder.
Uses :Vitamin K epoxide reductase inhibitor; oral anticoagulant (coumarin).

Product Name	Warfarin sodium
MF	C19H15O4.Na
CAS	129-06-6
Appearance	White Powder
Standard	USP

It is applicable to patients who need long-term continuous anticoagulation.

1. It is used to prevent and treat thromboembolic diseases, prevent the formation and development of thrombosis, such as prevention and treatment of deep vein thrombosis and thrombophlebitis, reduce the incidence rate and mortality of pulmonary embolism, and reduce the incidence of venous thrombosis in major surgery (including orthopedic surgery), rheumatic heart disease, artificial heart valve replacement, etc.

2. Auxiliary drugs for myocardial infarction, such as the treatment of atrial fibrillation with pulmonary embolism and coronary artery occlusion.